ORGANIC
LETTERS
2005
Vol. 7, No. 19
4221-4224
A Racemic Synthesis of an AB-Ring
System of Hexacyclinic Acid
Paul A. Clarke* and Andrew P. Cridland
School of Chemistry, UniVersity of Nottingham,
UniVersity Park, Nottingham, NG7 2RD, United Kingdom
Received July 12, 2005
ABSTRACT
An AB-ring system of the polyketide natural product hexacyclinic acid has been synthesized in racemic form. The key steps were an intramolecular
Diels Alder cyclization of an ester tethered 1,3-nonadiene-8-yne, which generated the B-ring, and a samarium diiodide mediated reductive
−
annulation, which was used to form the A-ring.
Recently, the structure of hexacyclinic acid 1, a new poly-
ketide natural product was reported (Figure 1).1 This com-
pound was isolated from Streptomyces cellulosae subsp.
griseorubiginosus (strain S1013) and was shown to have
some cytotoxic activity when tested in three cell lines
(HM02, HEPG2, and MCF7). A similar compound, also with
cytotoxic activity, FR182877 (Figure 1), has also been
reported.2-4 FR182877 differs from hexacyclinic acid in the
relative stereochemical configurations around the six-
membered B-ring and that a bridgehead double bond exists
where the cyclic hemiketal is in hexacyclinic acid. The B-ring
of hexacyclinic acid is functionalized by a carboxylic acid
residue, whereas this is a methyl group in FR182877. The
main other difference is in the acylation of the C9 hydroxyl
in hexacyclinic acid.
Figure 1. Structures of hexacyclinic acid and FR182877.
syntheses.5a,b Despite the similarities between hexacyclinic
acid and FR182877, there have been fewer reported routes
toward the hexacyclinic acid ring systems.5h,6
Our strategy for the synthesis of the ABC-rings of 1 was
to employ an ester tethered intramolecular Diels-Alder
The unique structural features and challenging nature of
these molecules have attracted the attention of several groups
across the world. This has led to the realization of several
strategies toward the FR182877 ring systems5 and two total
(5) (a) Vosburg, D. A.; Vanderwal, C. D.; Sorensen, E. J. J. Am. Chem.
Soc. 2002, 124, 4552. (b) Evans, D. A.; Starr, J. T. Angew. Chem., Int. Ed.
2002, 41, 1787. (c) Armstrong, A.; Goldberg, F. W.; Sandham, D. A.
Tetrahedron Lett. 2001, 42, 4585. (d) Suzuki, T.; Nakada, M. Tetrahedron
Lett. 2002, 43, 3263. (e) Methot, J. L.; Roush, W. R. Org. Lett. 2003, 5,
4223. (f) Funel, J.-A.; Prunet, J. J. Org. Chem. 2004, 69, 4555. (g) Clarke,
P. A.; Grist, M.; Ebden, M. Tetrahedron Lett. 2004, 45, 927. (h) Clarke, P.
A.; Grist, M.; Ebden, M.; Wilson, C., Blake, A. J. Tetrahedron 2005, 61,
353. (i) Clarke, P. A.; Davie, R.; Peace, S. Tetrahedron 2005, 61, 2335.
(1) Ho¨fs, R.; Walker, M.; Zeeck, A. Angew. Chem., Int. Ed. 2000, 39,
3258.
(2) Sato, B.; Muramatsu, H.; Miyauchi, M.; Hori, Y.; Takase, S.; Hino,
M.; Hashimoto, S.; Terano, H. J. Antibiot. 2000, 53, 123.
(3) Sato, B.; Nakajima, H.; Hori, Y.; Hino, M.; Hashimoto, S.; Terano,
H. J. Antibiot. 2000, 53, 204.
(4) Yoshimura, S.; Sato, B.; Kinoshita, T.; Takase, S.; Terano, H. J.
Antibiot. 2000, 53, 615.
10.1021/ol051633r CCC: $30.25
© 2005 American Chemical Society
Published on Web 08/23/2005